
NATURE . COM {
}
Title:
Reversibility and recurrence of IGF-IR-induced mammary tumors | Oncogene
Description:
The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Education
- Health & Fitness
- Science
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$63,100 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $42,042 to $115,616.
Keywords {π}
cancer, article, google, scholar, cas, growth, breast, insulinlike, receptor, factor, res, nature, oncogene, mammary, tumor, human, igfir, access, tumors, expression, cell, content, research, cookies, recurrence, jones, campbell, moorehead, transgenic, privacy, function, signaling, mouse, epithelial, transition, open, nat, type, monoclonal, antibody, pubmed, tumorigenesis, moody, ontario, data, petrik, targeting, development, model, transcriptional,
Topics {βοΈ}
nature portfolio permissions reprints privacy policy nature formalin-fixed paraffin-embedded tissues cancer research society tgf-beta-induced collagen expression c-myc-induced mammary adenocarcinomas advertising igf-ir-induced mammary tumors social media health research p19arf/p53 pathway lesions author information authors mammary gland development anti-igf-ir therapies real-time pcr primer conditional wnt-induced tumorigenesis targeting igf-ir author correspondence tumor-size-dependent regression endocrine-responsive breast cancer springerlink instant access personal data recombinant humanized anti-insulin tumor development igf-ir-independent mechanisms signal transduction function regulates epithelial plasticity data protection permissions invasive breast cancers transgenic mouse model igf-ir-dependent e-cadherin gene expression accelerates mammary tumorigenesis breast cancer cells kinase activity human breast cancer igf-ir dependence igf-ir independence human lung tumors igf-ir signaling igf-ir results growth factor receptor breast cancer panagiotis induces tumor formation metastasizing mammary carcinomas igf-ii mrna privacy
Questions {β}
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(127)
- How profitable is https://link.springer.com/article/10.1038/onc.2009.79?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle?
- How much income does https://doi.org/10.1038%2Fnrc2256 have?
- How much money does http://scholar.google.com/scholar_lookup?&title=Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2256&volume=7&pages=834-846&publication_year=2007&author=Aguirre-Ghiso%2CJA make?
- What is the earnings of https://doi.org/10.1038%2Fnrc721?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Endocrine-responsive%20breast%20cancer%20and%20strategies%20for%20combating%20resistance&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc721&volume=2&pages=101-112&publication_year=2002&author=Ali%2CS&author=Coombes%2CRC?
- What's the revenue for https://doi.org/10.1172%2FJCI114315?
- How much does http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20the%20type%20I%20somatomedin%20receptor%20inhibits%20growth%20of%20human%20breast%20cancer%20cells%20in%20athymic%20mice&journal=J%20Clin%20Invest&doi=10.1172%2FJCI114315&volume=84&pages=1418-1423&publication_year=1989&author=Arteaga%2CC&author=Kitten%2CK&author=Coronado%2CE make?
- Learn how profitable https://doi.org/10.1038%2Fbjc.1995.484 is on a monthly basis
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Mammary%20cancer%20in%20transgenic%20mice%20expressing%20insulin-like%20growth%20factor%20II%20%28IGF-II%29&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1995.484&volume=72&pages=1189-1193&publication_year=1995&author=Bates%2CP&author=Fisher%2CR&author=Ward%2CA&author=Richardson%2CL&author=Hill%2CDJ&author=Graham%2CCF
- Profit of https://doi.org/10.1016%2Fj.ccr.2004.10.013
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Lack%20of%20sustained%20regression%20of%20c-MYC-induced%20mammary%20adenocarcinomas%20following%20brief%20or%20prolonged%20MYC%20inactivation&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2004.10.013&volume=6&pages=577-586&publication_year=2004&author=Boxer%2CRB&author=Jang%2CJW&author=Sintasath%2CL&author=Chodosh%2CLA?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14695208's gross income?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=A%20fully%20human%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor%20blocks%20ligand-dependent%20signaling%20and%20inhibits%20human%20tumor%20growth%20in%20vivo&journal=Cancer%20Res&volume=63&pages=8912-8921&publication_year=2003&author=Burtrum%2CD&author=Zhu%2CZ&author=Lu%2CD&author=Anderson%2CDM&author=Prewett%2CM&author=Pereira%2CDS
- How profitable is https://doi.org/10.1158%2F0008-5472.CAN-04-4602?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Tumor%20development%20by%20transgenic%20expression%20of%20a%20constitutively%20active%20insulin-like%20growth%20factor%20I%20receptor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-4602&volume=65&pages=3781-3787&publication_year=2005&author=Carboni%2CJM&author=Lee%2CAV&author=Hadsell%2CDL&author=Rowley%2CBR&author=Lee%2CFY&author=Bol%2CDK?
- How much does https://doi.org/10.1158%2F0008-5472.CAN-06-2044 generate monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Mesenchymal-to-epithelial%20transition%20facilitates%20bladder%20cancer%20metastasis%3A%20role%20of%20fibroblast%20growth%20factor%20receptor-2&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2044&volume=66&pages=11271-11278&publication_year=2006&author=Chaffer%2CCL&author=Brennan%2CJP&author=Slavin%2CJL&author=Blick%2CT&author=Thompson%2CEW&author=Williams%2CED
- How much profit is https://doi.org/10.1038%2Fsj.cgt.7700126 making per month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20human%20breast%20cancer%20cells%20with%20antisense%20RNA%20to%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%20inhibits%20cell%20growth%2C%20suppresses%20tumorigenesis%2C%20alters%20the%20metastatic%20potential%2C%20and%20prolongs%20survival%20in%20vivo&journal=Cancer%20Gene%20Ther&doi=10.1038%2Fsj.cgt.7700126&volume=7&pages=384-395&publication_year=2000&author=Chernicky%2CCL&author=Yi%2CL&author=Tan%2CH&author=Gan%2CSU&author=Ilan%2CJ?
- https://doi.org/10.1038%2F84691's total income per month
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=c-MYC%20induces%20mammary%20tumorigenesis%20by%20means%20of%20a%20preferred%20pathway%20involving%20spontaneous%20Kras2%20mutations&journal=Nat%20Med&doi=10.1038%2F84691&volume=7&pages=235-239&publication_year=2001&author=D%E2%80%99Cruz%2CCM&author=Gunther%2CEJ&author=Boxer%2CRB&author=Hartman%2CJL&author=Sintasath%2CL&author=Moody%2CSE have monthly?
- How much profit is https://doi.org/10.1172%2FJCI33320 making per month?
- http://scholar.google.com/scholar_lookup?&title=Tumor%20escape%20in%20a%20Wnt1-dependent%20mouse%20breast%20cancer%20model%20is%20enabled%20by%20p19Arf%2Fp53%20pathway%20lesions%20but%20not%20p16%20Ink4a%20loss&journal=J%20Clin%20Invest&doi=10.1172%2FJCI33320&volume=118&pages=51-63&publication_year=2008&author=Debies%2CMT&author=Gestl%2CSA&author=Mathers%2CJL&author=Mikse%2COR&author=Leonard%2CTL&author=Moody%2CSE income
- How much does https://link.springer.com/doi/10.1007/s10549-006-9168-1 pull in monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20growth%20hormone%20receptor%20antagonist%20pegvisomant%20blocks%20both%20mammary%20gland%20development%20and%20MCF-7%20breast%20cancer%20xenograft%20growth&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-006-9168-1&volume=98&pages=315-327&publication_year=2006&author=Divisova%2CJ&author=Kuiatse%2CI&author=Lazard%2CZ&author=Weiss%2CH&author=Vreeland%2CF&author=Hadsell%2CDL generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9699666 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=A%20dominant%20negative%20mutant%20of%20the%20insulin-like%20growth%20factor-I%20receptor%20inhibits%20the%20adhesion%2C%20invasion%20and%20metastasis%20of%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=3353-3361&publication_year=1998&author=Dunn%2CSE&author=Ehrlich%2CM&author=Sharp%2CNJ&author=Keiss%2CK&author=Solomon%2CG&author=Hawkins%2CR make?
- Get to know https://doi.org/10.1038%2Fsj.onc.1208429's earnings
- Earnings of http://scholar.google.com/scholar_lookup?&title=DeltaEF1%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20and%20regulates%20epithelial%20plasticity%20in%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1208429&volume=24&pages=2375-2385&publication_year=2005&author=Eger%2CA&author=Aigner%2CK&author=Sonderegger%2CS&author=Dampier%2CB&author=Oehler%2CS&author=Schreiber%2CM
- How much does https://doi.org/10.1158%2F1535-7163.MCT-05-0252 rake in every month?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Novel%20human%20monoclonal%20antibodies%20to%20insulin-like%20growth%20factor%20%28IGF%29-II%20that%20potently%20inhibit%20the%20IGF%20receptor%20type%20I%20signal%20transduction%20function&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-05-0252&volume=5&pages=114-120&publication_year=2006&author=Feng%2CY&author=Zhu%2CZ&author=Xiao%2CX&author=Choudhry%2CV&author=Barrett%2CJC&author=Dimitrov%2CDS?
- What's the monthly income of https://link.springer.com/doi/10.1007/BF01807035?
- What's http://scholar.google.com/scholar_lookup?&title=IGF-II%20mRNA%20and%20protein%20are%20expressed%20in%20the%20stroma%20of%20invasive%20breast%20cancers%3A%20an%20in%20situ%20hybridization%20and%20immunohistochemistry%20study&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01807035&volume=41&pages=43-50&publication_year=1996&author=Giani%2CC&author=Cullen%2CKJ&author=Campani%2CD&author=Rasmussen%2CA's gross income?
- What's the revenue for https://doi.org/10.1002%2Fijc.20543?
- Get to know http://scholar.google.com/scholar_lookup?&title=A%20recombinant%20humanized%20anti-insulin-like%20growth%20factor%20receptor%20type%20I%20antibody%20%28h7C10%29%20enhances%20the%20antitumor%20activity%20of%20vinorelbine%20and%20anti-epidermal%20growth%20factor%20receptor%20therapy%20against%20human%20cancer%20xenografts&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20543&volume=113&pages=316-328&publication_year=2005&author=Goetsch%2CL&author=Gonzalez%2CA&author=Leger%2CO&author=Beck%2CA&author=Pauwels%2CPJ&author=Haeuw%2CJF's earnings
- Learn how profitable https://doi.org/10.1101%2Fgad.1051603 is on a monthly basis
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Impact%20of%20p53%20loss%20on%20reversal%20and%20recurrence%20of%20conditional%20Wnt-induced%20tumorigenesis&journal=Genes%20Dev&doi=10.1101%2Fgad.1051603&volume=17&pages=488-501&publication_year=2003&author=Gunther%2CEJ&author=Moody%2CSE&author=Belka%2CGK&author=Hahn%2CKT&author=Innocent%2CN&author=Dugan%2CKD?
- How much does https://doi.org/10.1038%2Fsj.onc.1203386 rake in every month?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Cooperative%20interaction%20between%20mutant%20p53%20and%20des%281-3%29IGF-I%20accelerates%20mammary%20tumorigenesis&journal=Oncogene&doi=10.1038%2Fsj.onc.1203386&volume=19&pages=889-898&publication_year=2000&author=Hadsell%2CDL&author=Murphy%2CKL&author=Bonnette%2CSG&author=Reece%2CN&author=Laucirica%2CR&author=Rosen%2CJM?
- Learn about the earnings of https://doi.org/10.1158%2F1078-0432.CCR-07-1118
- How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20I%20dose%20escalation%20study%20of%20the%20anti%20insulin-like%20growth%20factor-I%20receptor%20monoclonal%20antibody%20CP-751%2C871%20in%20patients%20with%20refractory%20solid%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1118&volume=13&pages=5834-5840&publication_year=2007&author=Haluska%2CP&author=Shaw%2CHM&author=Batzel%2CGN&author=Yin%2CD&author=Molina%2CJR&author=Molife%2CLR make?
- Earnings of https://doi.org/10.1016%2FS0140-6736%2897%2910384-1
- How profitable is http://scholar.google.com/scholar_lookup?&title=Circulating%20concentrations%20of%20insulin-like%20growth%20factor-I%20and%20risk%20of%20breast%20cancer&journal=Lancet&doi=10.1016%2FS0140-6736%2897%2910384-1&volume=351&pages=1393-1396&publication_year=1998&author=Hankinson%2CSE&author=Willett%2CWC&author=Colditz%2CGA&author=Hunter%2CDJ&author=Michaud%2CDS&author=Deroo%2CB?
- Monthly income for https://doi.org/10.1056%2FNEJMra043186
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Trastuzumab%E2%80%94mechanism%20of%20action%20and%20use%20in%20clinical%20practice&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMra043186&volume=357&pages=39-51&publication_year=2007&author=Hudis%2CCA
- What's https://doi.org/10.1002%2Fjcp.21223's gross income?
- What's http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20and%20mesenchymal-epithelial%20transitions%20in%20carcinoma%20progression&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.21223&volume=213&pages=374-383&publication_year=2007&author=Hugo%2CH&author=Ackland%2CML&author=Blick%2CT&author=Lawrence%2CMG&author=Clements%2CJA&author=Williams%2CED's gross income?
- What's the financial outcome of https://doi.org/10.1038%2Fsj.onc.1209955?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Transgenic%20overexpression%20of%20IGF-IR%20disrupts%20mammary%20ductal%20morphogenesis%20and%20induces%20tumor%20formation&journal=Oncogene&doi=10.1038%2Fsj.onc.1209955&volume=26&pages=1636-1644&publication_year=2007&author=Jones%2CRA&author=Campbell%2CCI&author=Gunther%2CEJ&author=Chodosh%2CLA&author=Petrik%2CJJ&author=Khokha%2CR
- What's the financial outcome of https://doi.org/10.1158%2F1541-7786.MCR-07-2157?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20novel%20primary%20mammary%20tumor%20cell%20line%20reveals%20that%20cyclin%20D1%20is%20regulated%20by%20the%20type%20I%20insulin-like%20growth%20factor%20receptor&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-07-2157&volume=6&pages=819-828&publication_year=2008&author=Jones%2CRA&author=Campbell%2CCI&author=Petrik%2CJJ&author=Moorehead%2CRA
- What are the total earnings of https://doi.org/10.1073%2Fpnas.0611192104?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=MicroRNA-192%20in%20diabetic%20kidney%20glomeruli%20and%20its%20function%20in%20TGF-beta-induced%20collagen%20expression%20via%20inhibition%20of%20E-box%20repressors&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0611192104&volume=104&pages=3432-3437&publication_year=2007&author=Kato%2CM&author=Zhang%2CJ&author=Wang%2CM&author=Lanting%2CL&author=Yuan%2CH&author=Rossi%2CJJ?
- What's the revenue for https://doi.org/10.2325%2Fjbcs.954?
- http://scholar.google.com/scholar_lookup?&title=Current%20clinical%20trials%20of%20endocrine%20therapy%20for%20breast%20cancer&journal=Breast%20Cancer&doi=10.2325%2Fjbcs.954&volume=14&pages=200-214&publication_year=2007&author=Kurebayashi%2CJ's revenue stream
- How much income is https://doi.org/10.1016%2FS0304-3835%2803%2900159-9 earning monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20insulin-like%20growth%20factor%20system%20and%20cancer&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2803%2900159-9&volume=195&pages=127-137&publication_year=2003&author=LeRoith%2CD&author=Roberts%2CCT generate?
- Find out how much https://doi.org/10.1002%2Fijc.20814 earns monthly
- How much money does http://scholar.google.com/scholar_lookup?&title=Use%20of%20a%20transgenic%20mouse%20model%20to%20identify%20markers%20of%20human%20lung%20tumors&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20814&volume=114&pages=977-982&publication_year=2005&author=Linnerth%2CNM&author=Sirbovan%2CK&author=Moorehead%2CRA generate?
- What are the total earnings of https://doi.org/10.1093%2Fjnci%2F93.24.1852?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-I%20receptor%20signaling%20and%20resistance%20to%20trastuzumab%20%28Herceptin%29&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F93.24.1852&volume=93&pages=1852-1857&publication_year=2001&author=Lu%2CY&author=Zi%2CX&author=Zhao%2CY&author=Mascarenhas%2CD&author=Pollak%2CM bring in?
- How much does https://doi.org/10.1016%2FS1535-6108%2804%2900050-9 generate monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20the%20insulin-like%20growth%20factor%20receptor-1%20tyrosine%20kinase%20activity%20as%20a%20therapeutic%20strategy%20for%20multiple%20myeloma%2C%20other%20hematologic%20malignancies%2C%20and%20solid%20tumors&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2804%2900050-9&volume=5&pages=221-230&publication_year=2004&author=Mitsiades%2CCS&author=Mitsiades%2CNS&author=McMullan%2CCJ&author=Poulaki%2CV&author=Shringarpure%2CR&author=Akiyama%2CM?
- https://doi.org/10.1016%2Fj.ccr.2005.07.009's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=The%20transcriptional%20repressor%20Snail%20promotes%20mammary%20tumor%20recurrence&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.07.009&volume=8&pages=197-209&publication_year=2005&author=Moody%2CSE&author=Perez%2CD&author=Pan%2CTC&author=Sarkisian%2CCJ&author=Portocarrero%2CCP&author=Sterner%2CCJ make?
- How much profit does https://doi.org/10.1016%2FS1535-6108%2802%2900212-X generate?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Conditional%20activation%20of%20Neu%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20results%20in%20reversible%20pulmonary%20metastasis&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2802%2900212-X&volume=2&pages=451-461&publication_year=2002&author=Moody%2CSE&author=Sarkisian%2CCJ&author=Hahn%2CKT&author=Gunther%2CEJ&author=Pickup%2CS&author=Dugan%2CKD
- What's the profit of https://doi.org/10.1038%2Fsj.onc.1210379?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%3A%20triumphs%20and%20tribulations&journal=Oncogene&doi=10.1038%2Fsj.onc.1210379&volume=26&pages=3637-3643&publication_year=2007&author=Nahta%2CR&author=Esteva%2CFJ
- What are the total earnings of https://doi.org/10.1016%2Fj.bcp.2007.10.032?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytochrome%20P450%202A5%20in%20a%20glucose-6-phosphate%20dehydrogenase-deficient%20mouse%20model%20of%20oxidative%20stress&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2007.10.032&volume=75&pages=1230-1239&publication_year=2008&author=Nichols%2CKD&author=Kirby%2CGM bring in?
- https://link.springer.com/doi/10.1007/BF01833331 income
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20IGF-I%20and%20IGF-II%20mRNA%20in%20breast%20tissue&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01833331&volume=22&pages=31-38&publication_year=1992&author=Paik%2CS pull in?
- Income figures for https://doi.org/10.1038%2Fsj.bjc.6690112
- How much does http://scholar.google.com/scholar_lookup?&title=Altered%20expression%20of%20the%20IGF-1%20receptor%20in%20a%20tamoxifen-resistant%20human%20breast%20cancer%20cell%20line&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690112&volume=79&pages=693-700&publication_year=1999&author=Parisot%2CJP&author=Hu%2CXF&author=DeLuise%2CM&author=Zalcberg%2CJR bring in each month?
- How much does https://doi.org/10.1093%2Fnar%2Fgkj155 earn?
- Earnings of http://scholar.google.com/scholar_lookup?&title=RTPrimerDB%3A%20the%20real-time%20PCR%20primer%20and%20probe%20database%2C%20major%20update%202006&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkj155&volume=34&pages=D684-D688&publication_year=2006&author=Pattyn%2CF&author=Robbrecht%2CP&author=De%2CPA&author=Speleman%2CF&author=Vandesompele%2CJ
- How much money does https://doi.org/10.1038%2Fnrc2131 generate?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Snail%2C%20Zeb%20and%20bHLH%20factors%20in%20tumour%20progression%3A%20an%20alliance%20against%20the%20epithelial%20phenotype%3F&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2131&volume=7&pages=415-428&publication_year=2007&author=Peinado%2CH&author=Olmeda%2CD&author=Cano%2CA?
- What's the monthly income of https://doi.org/10.1073%2Fpnas.0801197105?
- http://scholar.google.com/scholar_lookup?&title=Oncogene%20cooperation%20in%20tumor%20maintenance%20and%20tumor%20recurrence%20in%20mouse%20mammary%20tumors%20induced%20by%20Myc%20and%20mutant%20Kras&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0801197105&volume=105&pages=5242-5247&publication_year=2008&author=Podsypanina%2CK&author=Politi%2CK&author=Beverly%2CLJ&author=Varmus%2CHE's revenue stream
- What's the revenue for https://doi.org/10.1038%2Fnrc1387?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factors%20and%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1387&volume=4&pages=505-518&publication_year=2004&author=Pollak%2CMN&author=Schernhammer%2CES&author=Hankinson%2CSE
- Get to know what's the income of https://doi.org/10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C
- Earnings of http://scholar.google.com/scholar_lookup?&title=Metastasizing%20mammary%20carcinomas%20in%20H19%20enhancers-Igf2%20transgenic%20mice&journal=J%20Exp%20Zool&doi=10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C&volume=281&pages=43-57&publication_year=1998&author=Pravtcheva%2CDD&author=Wise%2CTL
- How much profit does https://doi.org/10.1016%2FS0140-6736%2804%2916044-3 generate?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20%28IGF%29-I%2C%20IGF%20binding%20protein-3%2C%20and%20cancer%20risk%3A%20systematic%20review%20and%20meta-regression%20analysis&journal=Lancet&doi=10.1016%2FS0140-6736%2804%2916044-3&volume=363&pages=1346-1353&publication_year=2004&author=Renehan%2CAG&author=Zwahlen%2CM&author=Minder%2CC&author=O%E2%80%99Dwyer%2CST&author=Shalet%2CSM&author=Egger%2CM making per month?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9515800?
- Profit of http://scholar.google.com/scholar_lookup?&title=Elevated%20insulin-like%20growth%20factor%20I%20receptor%20autophosphorylation%20and%20kinase%20activity%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=1159-1164&publication_year=1998&author=Resnik%2CJL&author=Reichart%2CDB&author=Huey%2CK&author=Webster%2CNJG&author=Seely%2CBL
- What are the earnings of https://doi.org/10.1158%2F1078-0432.CCR-07-1109?
- Find out how much http://scholar.google.com/scholar_lookup?&title=IMC-A12%2C%20a%20human%20IgG1%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1109&volume=13&pages=5549s-5555s&publication_year=2007&author=Rowinsky%2CEK&author=Youssoufian%2CH&author=Tonra%2CJR&author=Solomon%2CP&author=Burtrum%2CD&author=Ludwig%2CDL earns monthly
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7757999 makes per month
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Malignant%20breast%20epithelium%20selects%20for%20insulin-like%20growth%20factor%20II%20expression%20in%20breast%20stroma%3A%20evidence%20for%20paracrine%20function&journal=Cancer%20Res&volume=55&pages=2448-2454&publication_year=1995&author=Singer%2CC&author=Rasmussen%2CA&author=Smith%2CHS&author=Lippman%2CME&author=Lynch%2CHT&author=Cullen%2CKJ
- How much does https://doi.org/10.1056%2FNEJM200103153441101 generate monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Use%20of%20chemotherapy%20plus%20a%20monoclonal%20antibody%20against%20HER2%20for%20metastatic%20breast%20cancer%20that%20overexpresses%20HER2&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200103153441101&volume=344&pages=783-792&publication_year=2001&author=Slamon%2CDJ&author=Leyland-Jones%2CB&author=Shak%2CS&author=Fuchs%2CH&author=Paton%2CV&author=Bajamonde%2CA
- How much revenue does https://doi.org/10.1023%2FA%3A1009523501499 bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=Function%20of%20the%20IGF-I%20receptor%20in%20breast%20cancer&journal=J%20Mam%20Gland%20Biol%20Neoplasia&doi=10.1023%2FA%3A1009523501499&volume=5&pages=95-105&publication_year=2000&author=Surmacz%2CE rake in every month?
- How much income is https://doi.org/10.1016%2Fj.bbrc.2007.11.151 earning monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Twist%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20gene%20expression%20in%20breast%20cancer&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2007.11.151&volume=367&pages=235-241&publication_year=2008&author=Vesuna%2CF&author=van%2CDP&author=Chen%2CJH&author=Raman%2CV generate?
- How much profit does https://doi.org/10.1016%2Fj.cell.2004.06.006 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Twist%2C%20a%20master%20regulator%20of%20morphogenesis%2C%20plays%20an%20essential%20role%20in%20tumor%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2004.06.006&volume=117&pages=927-939&publication_year=2004&author=Yang%2CJ&author=Mani%2CSA&author=Donaher%2CJL&author=Ramaswamy%2CS&author=Itzykson%2CRA&author=Come%2CC rake in every month?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180080 makes per month
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20II%20mRNA%20expression%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=48&pages=6691-6696&publication_year=1988&author=Yee%2CD&author=Cullen%2CKJ&author=Paik%2CS&author=Perdue%2CJF&author=Hampton%2CB&author=Schwartz%2CA?
- What's the monthly money flow for https://doi.org/10.1210%2Fmend-3-3-509?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20insulin-like%20growth%20factor%20I%20gene%20expression%20in%20malignancy%3A%20evidence%20for%20a%20paracrine%20role%20in%20human%20breast%20cancer&journal=Mol%20Endocrinol&doi=10.1210%2Fmend-3-3-509&volume=3&pages=509-517&publication_year=1989&author=Yee%2CD&author=Paik%2CS&author=Lebovic%2CGS&author=Marcus%2CRR&author=Favoni%2CRE&author=Cullen%2CKJ bring in?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=references bring in?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Jones's financial summary
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Jones%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20I%20Campbell?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20I%20Campbell%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20A%20Wood gross monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20A%20Wood%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20J%20Petrik makes per month
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20J%20Petrik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Moorehead
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Moorehead%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- How much profit is https://s100.copyright.com/AppDispatchServlet?title=Reversibility%20and%20recurrence%20of%20IGF-IR-induced%20mammary%20tumors&author=R%20A%20Jones%20et%20al&contentID=10.1038%2Fonc.2009.79©right=Macmillan%20Publishers%20Limited&publication=0950-9232&publicationDate=2009-04-20&publisherName=SpringerNature&orderBeanReset=true making per month?
- What are the total earnings of https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=citation?
- Get to know https://doi.org/10.1038/s41388-018-0362-5's earnings
- What's the income generated by https://doi.org/10.1186/s12943-015-0291-7 each month?
- How much revenue does https://doi.org/10.1038/onc.2013.373 bring in?
- How much revenue does https://doi.org/10.1038/onc.2012.4 generate?
- What are the earnings of https://doi.org/10.1007/s12282-011-0299-9?
- What's https://www.protocols.io/'s gross income?
- Find out how much https://www.natureindex.com/ earns monthly
- How much does http://www.naturechina.com make?
- What's the monthly money flow for https://www.natureasia.com/ja-jp?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk